HPV Prevalence in Males
Approximately 31% of males worldwide carry genital HPV infection at any given time, with about 21% infected with high-risk HPV types. 1
Global Prevalence Data
The most comprehensive and recent meta-analysis examining 44,769 men across 35 countries provides robust global estimates 1:
- Any HPV type: 31% (95% CI 27-35%)
- High-risk HPV types: 21% (95% CI 18-24%)
- HPV-16 (most common oncogenic type): 5% (95% CI 4-7%)
- HPV-6 (most common low-risk type): 4% (95% CI 3-5%)
Age-Specific Patterns
Unlike women, HPV prevalence in men remains relatively constant across age groups 2. The incidence rates are:
- Ages 18-30: 39 cases per 100 person-years
- Ages 31-44: 41 cases per 100 person-years
- Ages 45-70: 33 cases per 100 person-years
This contrasts sharply with women, where prevalence declines dramatically with age (from 17 per 100 person-years in ages 15-19 to 1.5 per 100 person-years after age 55) 2.
Peak prevalence occurs between ages 25-29 years, then stabilizes or slightly decreases 1. This persistent high prevalence across the male lifespan makes sexually active men an important ongoing reservoir for HPV transmission.
Site-Specific Infection Rates
HPV prevalence varies by anatomical location 2:
- Anogenital region: 29-40% cumulative incidence over 12 months in sexually active adults
- Oropharyngeal region: 10.1% in men (versus 3.6% in women)
Regional Variations
The 2023 meta-analysis found similar prevalence across most UN regions 1:
- Europe and Northern America
- Sub-Saharan Africa
- Latin America and the Caribbean
- Australia and New Zealand
Eastern and South-Eastern Asia showed approximately half the prevalence of other regions 1, though this may reflect differences in sexual behaviors, cultural norms, or study methodologies.
High-Risk Populations
Certain male populations show substantially elevated rates 2:
- HIV-positive MSM: 85 cases of anal cancer per 100,000 person-years
- HIV-negative MSM: 19 cases of anal cancer per 100,000 person-years
- HIV-positive heterosexual men: 32 cases of anal cancer per 100,000 person-years
Clinical Implications
These prevalence data underscore that sexually active men of all ages represent a critical reservoir for HPV transmission 1. The 12-month cumulative incidence of 29-40% among sexually active adults demonstrates rapid transmission dynamics 2.
Approximately 70,000 cases of penile, anal, oropharyngeal, and other head/neck cancers occur annually in men globally, with over 80% caused by HPV-16 and HPV-18 2. This substantial disease burden, combined with the high and persistent male prevalence, provides strong rationale for including men in comprehensive HPV vaccination strategies 1.
The evidence demonstrates that at least half of all sexually active individuals acquire HPV at some point in their lifetime, with modeling suggesting up to 80% of sexually active women will have been infected by age 50 3. Given similar cumulative incidence rates between men and women, comparable lifetime infection rates likely apply to men 2.